Sopheon (SPE) Share Price, News & Analysis

Company Overview

Sopheon plc designs, develops, and markets software products with associated implementation and consultancy services in North America and Europe. Its software solutions include Accolade, an enterprise management solution that identify, evaluate, and execute against the right strategic priorities for its portfolio; Acclaim Ideas, an idea management solution; Acclaim Products, which allows product people to track product health, prioritize trade-offs, inform stakeholders, and make decisions; and Acclaim Projects, a project management solution. The company was formerly known as PolyDoc and changed its name to Sopheon plc in 1999. Sopheon plc was founded in 1993 and is based in West End, the United Kingdom.

Key Stats

• Today's Range: 990 to 990
• 50-Day Range: 990 to 990
• 52-Week Range: 470 to 1,000
• Volume: 1,136 shs
• Average Volume: 36,595 shs
• Market Capitalization: £106.03 million
• P/E Ratio: N/A
• Dividend Yield: 0.30%
• Price Target: N/A
• Consensus Rating: N/A

SPE Stock Analysis - Frequently Asked Questions

How have SPE shares performed this year?

Sopheon's stock was trading at GBX 970 on January 1st, 2024. Since then, SPE stock has increased by 2.1% and is now trading at GBX 990.
View the best growth stocks for 2024 here.

How do I buy shares of Sopheon?

Shares of SPE stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Sopheon own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sopheon investors own include Galapagos (GLPG), Pharming Group (PHGUF), Kratos Defense & Security Solutions (KTOS), MyoKardia (MYOK), Laboratory Co. of America (LH), NVR (NVR) and Pacira BioSciences (PCRX).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Computer and Technology
• Industry: Software - Application
• Sub-Industry: Financial Services
• Current Symbol: LON:SPE
• CUSIP: N/A
• CIK: N/A
• Web: www.sopheon.com
• Phone: +44-1276-919560
• Fax: N/A
• Employees: 174
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 109.89
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: -0.14%
• Pretax Margin: N/A
• Return on Equity: -0.18%
• Return on Assets: 2.70%

Debt

• Debt-to-Equity Ratio: 1.74
• Current Ratio: 1.78
• Quick Ratio: 1.65

Sales & Book Value

• Annual Sales: £38.12 million
• Price / Sales: 2.78
• Cash Flow: GBX 376.71 per share
• Price / Cash Flow: 2.63
• Book Value: GBX 281 per share
• Price / Book: 3.52

Miscellaneous

• Outstanding Shares: 10,710,000
• Free Float: N/A
• Market Cap: £106.03 million
• Optionable: Not Optionable
• Beta: 0.44